Associated Skin Care Professionals

AUGUST 14, 2023

Osmosis uses a unique combination of active ingredients that focuses on three important factors: our pharmaceutical-grade delivery system, because most aging occurs deep within the skin; our patented products that create real changes in the skin; and our unique inside-out approach that triggers collagen/elastin and plumps the volume of the face.

Vitamin C 52

Vitamin C Pharmaceutical Collagen Ingredients 52

The Dermatology Digest

APRIL 22, 2024

Adult atopic dermatitis (AD) patients previously treated with dupilumab (Dupixent, Regeneron and Sanofi) who received 400mg eblasakimab weekly achieved Eczema Area Severity Index (EASI) 90, and 66.7% Treatment was well-tolerated and no new safety signals were identified.

Pharmaceutical 36

Pharmaceutical Dermatitis Eczema Injections 36

The Dermatology Digest

MARCH 13, 2024

Silverberg, MD, Chief of Pediatric Dermatology for the Mount Sinai Health System in New York, reviews the rationale for treating Molluscum Contagiosum and shares updates on available treatments including disruptive techniques and the newly approved Zelsuvmi (berdazimer topical gel, 10.3% (Zelsuvmi, Ligand) cantharidin (Ycanth, Verrica).

Treatments 28

Treatments Dermatitis Dermatology Eczema 28

First Derm

FEBRUARY 21, 2024

There’s a crucial difference between cosmetic retinol use and medical treatment with retinoids ; the latter is for specific skin conditions under professional supervision. A dermatologist can provide personalized recommendations and treatment plans tailored to your child’s specific needs.

Retinol 80

Retinol Social Media Skincare Routine Skincare 80

First Derm

DECEMBER 26, 2023

Consult Healthcare Providers When Necessary : Seek professional advice for persistent, severe, or unusual scalp symptoms to ensure accurate diagnosis and effective treatment. 3] Treatment – Dandruff Shampoos: Key Ingredients : Ketoconazole, selenium sulfide, pyrithione zinc, coal tar, salicylic acid.

Management 49

Management Dermatitis Eczema Consultations 49

The Dermatology Digest

MARCH 8, 2024

LEO Pharma recently acquired TMB-001 and other assets from Timber Pharmaceuticals following Timber’s Chapter 11 bankruptcy filing. If and when we receive FDA approval, we will consider this treatment as a potential part of lifestyle management for CI. Will we see a focus on orphan diseases from LEO Pharma?

Pharmaceutical 36

Pharmaceutical Eczema Dermatology Innovations 36

The Dermatology Digest

JANUARY 16, 2024

Food and Drug Administration (FDA) has updated the label for dupilumab (Dupixent, Regeneron Pharmaceuticals, Inc. “It is important to have systemic treatments approved for CHE, both with and without atopic dermatitis. “It is important to have systemic treatments approved for CHE, both with and without atopic dermatitis.

Dermatitis 36

Dermatitis Pharmaceutical Safety Eczema 36

The Dermatology Digest

MARCH 11, 2024

Raj Chovatiya, MD, PhD, Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago, urges viewers to consider AD mimickers, especially when treatment isn’t working.

Dermatitis 36

Dermatitis Eczema Dermatology Pharmaceutical 36

The Dermatology Digest

MARCH 11, 2024

Watch Now Chronic Hand Eczema 101 Jonathan Silverberg, MD, PhD, MPH Chronic hand eczema (CHE) symptoms can take a dramatic toll on patients’ quality of life.

Dermatitis 36

Dermatitis Eczema Dermatology Pharmaceutical 36

The Dermatology Digest

MARCH 11, 2024

Watch Now Chronic Hand Eczema 101 Jonathan Silverberg, MD, PhD, MPH Chronic hand eczema (CHE) symptoms can take a dramatic toll on patients’ quality of life. Del Rosso, DO, a dermatologist in Las Vegas, NV, and the new President of the American Acne and Rosacea Society.

Dermatitis 36

Dermatitis Eczema Dermatology Pharmaceutical 36

The Dermatology Digest

MARCH 13, 2024

Single-cell profiling of alopecia areata (AA) can provide key insights into immune-targeting treatment strategies. Raj Chovatiya, MD, PhD, Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago, urges viewers to consider AD mimickers, especially when treatment isn’t working.

Dermatitis 36

Dermatitis Dermatology Clinic Eczema 36

The Dermatology Digest

MARCH 13, 2024

Raj Chovatiya, MD, PhD, Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago, urges viewers to consider AD mimickers, especially when treatment isn’t working. Watch Now Molluscum Contagiosum Treatment Update Nanette B. Silverberg, MD Nanette B.

Dermatitis 36

Dermatitis Dermatology Clinic Eczema 36

The Dermatology Digest

MARCH 13, 2024

Raj Chovatiya, MD, PhD, Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago, urges viewers to consider AD mimickers, especially when treatment isn’t working. Watch Now Molluscum Contagiosum Treatment Update Nanette B. Silverberg, MD Nanette B.

Dermatitis 36

Dermatitis Dermatology Clinic Skin Issues 36

The Dermatology Digest

DECEMBER 15, 2023

Specifically, in the TRuE-AD3 trial, children aged 2 to 12 with AD who were treated with ruxolitinib cream achieved significant efficacy, as defined by the Investigator’s Global Assessment-treatment success following eight weeks of treatment. Finally, we have a new option for our HS patients who need more treatment options,” she says.

Dermatology 36

Dermatology Pharmaceutical Clinic Therapy 36

The Dermatology Digest

DECEMBER 15, 2023

Specifically, in the TRuE-AD3 trial, children aged 2 to 12 with AD who were treated with ruxolitinib cream achieved significant efficacy, as defined by the Investigator’s Global Assessment-treatment success following eight weeks of treatment. Finally, we have a new option for our HS patients who need more treatment options,” she says.

Dermatology 36

Dermatology Pharmaceutical Clinic Therapy 36

The Dermatology Digest

MARCH 14, 2024

Christopher Bunick, MD, PhD, an associate professor of dermatology at Yale University in New Haven, CT, shares some congenital ichthyosis (CI) cases and discusses the importance of understanding patient and family expectations about CI treatment.

Dermatitis 36

Dermatitis Dermatology Clinic Eczema 36

The Dermatology Digest

MARCH 14, 2024

Chronic spontaneous urticaria (CSU) often has no identifiable trigger and is driven by mast cells, but symptoms are bothersome to patients, highlighting the need for effective treatments, says Jason Hawkes, MD, MS, a dermatologist in Rocklin, CA.

Dermatitis 36

Dermatitis Dermatology Clinic Eczema 36

The Dermatology Digest

MARCH 14, 2024

Watch Now Diagnosing AA: Making the Case for Single-cell Profiling Elizabeth Swanson, MD Single-cell profiling of alopecia areata (AA) can provide key insights into immune-targeting treatment strategies.

Dermatitis 36

Dermatitis Dermatology Clinic Eczema 36

The Dermatology Digest

MARCH 13, 2024

Watch Now Off-label Pearl: Exploring the Role of Narrowband UVB Phototherapy Plus Oral JAK Inhibitors in Vitiligo Emma Guttman-Yassky, MD, PhD Adding narrowband ultraviolet B phototherapy to treatment with ritlecitinib (Litfulo, Pfizer) in vitiligo may improve patient outcomes.

Dermatitis 28

Dermatitis Dermatology Eczema Clinic 28

The Dermatology Digest

AUGUST 4, 2023

Elisabeth Richard discusses phototherapy in today’s practice, including usage trends, its continued role in the treatment of numerous skin diseases, and the importance of continuing to offer it to patients as a therapeutic option. When I’m counseling patients I tell them a clearance course is typically about 25 to 30 treatments.

Eczema 36

Eczema Private Practice Therapy Dermatitis 36

US Dermatologt Partners

JANUARY 7, 2025

And some of the reviews authors were consultants for a skin care pharmaceutical company, presenting a conflict of interest. In-office treatments can also help, Dr. Jaliman added. However, the studies they reviewed had various limitations, including that they looked at small groups of women.

Collagen 36

Collagen Wrinkles Vitamin C Pharmaceutical 36